Biblio

Export 11 results:
Author Title Type [ Year(Desc)]
Filters: Author is Shaw, Leslie M  [Clear All Filters]
2011
C. R. Jack, Vemuri, P., Wiste, H. J., Weigand, S. D., Aisen, P. S., Trojanowski, J. Q., Shaw, L. M., Bernstein, M. A., Petersen, R. C., Weiner, M. W., and Knopman, D. S., “Evidence for ordering of Alzheimer disease biomarkers.”, Arch Neurol, vol. 68, no. 12, pp. 1526-35, 2011.
2013
C. R. Jack, Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., Lesnick, T. G., Pankratz, V. S., Donohue, M. C., and Trojanowski, J. Q., “Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers.”, Lancet Neurol, vol. 12, no. 2, pp. 207-16, 2013.
2016
T. C. Durazzo, Korecka, M., Trojanowski, J. Q., Weiner, M. W., Hara, R. O. ', Ashford, J. W., and Shaw, L. M., “Active Cigarette Smoking in Cognitively-Normal Elders and Probable Alzheimer's Disease is Associated with Elevated Cerebrospinal Fluid Oxidative Stress Biomarkers.”, J Alzheimers Dis, vol. 54, no. 1, pp. 99-107, 2016.
M. Berger, Nadler, J. W., Friedman, A., McDonagh, D. L., Bennett, E. R., Cooter, M., Qi, W., Laskowitz, D. T., Ponnusamy, V., Newman, M. F., Shaw, L. M., Warner, D. S., Mathew, J. P., and James, M. L., “The Effect of Propofol Versus Isoflurane Anesthesia on Human Cerebrospinal Fluid Markers of Alzheimer's Disease: Results of a Randomized Trial.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1299-310, 2016.
M. T. White, Shaw, L. M., and Xie, S. X., “Evaluation of Cerebrospinal Fluid Assay Variability in Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 2, pp. 463-70, 2016.
2017
M. Timmers, Barão, S., Van Broeck, B., Tesseur, I., Slemmon, J., de Waepenaert, K., Bogert, J., Shaw, L. M., Engelborghs, S., Moechars, D., Mercken, M., Van Nueten, L., Tritsmans, L., De Strooper, B., and Streffer, J. Rolf, “BACE1 Dynamics Upon Inhibition with a BACE Inhibitor and Correlation to Downstream Alzheimer's Disease Markers in Elderly Healthy Participants.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1437-1449, 2017.
K. D. Deters, Risacher, S. L., Kim, S., Nho, K., West, J. D., Blennow, K., Zetterberg, H., Shaw, L. M., Trojanowski, J. Q., Weiner, M. W., and Saykin, A. J., “Plasma Tau Association with Brain Atrophy in Mild Cognitive Impairment and Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1245-1254, 2017.
2018
O. M. Al-Janabi, Brown, C. A., Bahrani, A. A., Abner, E. L., Barber, J. M., Gold, B. T., Goldstein, L. B., Murphy, R. R., Nelson, P. T., Johnson, N. F., Shaw, L. M., Smith, C. D., Trojanowski, J. Q., Wilcock, D. M., and Jicha, G. A., “Distinct White Matter Changes Associated with Cerebrospinal Fluid Amyloid-β1-42 and Hypertension.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1095-1104, 2018.
H. Wang, Stewart, T., Toledo, J. B., Ginghina, C., Tang, L., Atik, A., Aro, P., Shaw, L. M., Trojanowski, J. Q., Galasko, D. R., Edland, S., Jensen, P. H., Shi, M., and Zhang, J., “A Longitudinal Study of Total and Phosphorylated α-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1541-1553, 2018.
2019
J. B. Toledo, Habes, M., Sotiras, A., Bjerke, M., Fan, Y., Weiner, M. W., Shaw, L. M., Davatzikos, C., and Trojanowski, J. Q., “APOE Effect on Amyloid-β PET Spatial Distribution, Deposition Rate, and Cut-Points.”, J Alzheimers Dis, vol. 69, no. 3, pp. 783-793, 2019.
2020
A. R. Trammell, McDaniel, D. J., Obideen, M., Okafor, M., Thomas, T. L., Goldstein, F. C., Shaw, L. M., and Hajjar, I. M., “Perceived Stress is Associated with Alzheimer's Disease Cerebrospinal Fluid Biomarkers in African Americans with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 77, no. 2, pp. 843-853, 2020.